Product correctly added to cart.

discount label
MF-438
View 3D

Biosynth logo

MF-438

CAS: 921605-87-0

Ref. 3D-WLB60587

25mg
952.00 €
50mg
1,247.00 €
100mg
1,995.00 €
Estimated delivery in United States, on Wednesday 19 Feb 2025

Product Information

Name:
MF-438
Description:

MF-438 is a new anticancer drug that has shown promising results in inhibiting the growth of skin cancer cells. MF-438 activates the metabolic pathways in cancer cells and blocks cell signaling pathways. It also inhibits tumor angiogenesis by suppressing the expression of vascular endothelial growth factor (VEGF) and its receptor, VEGFR2. This drug was tested on a variety of carcinoma cell lines and showed strong antitumor activity. It has also been shown to inhibit the formation of atherosclerotic lesions caused by high cholesterol levels in mice, which may be related to its ability to reduce LDL-cholesterol levels. MF-438 is not toxic for fetal bovine cells and can be used as an alternative to fetal calf serum when culturing certain types of cells.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
421.4 g/mol
Formula:
C19H18F3N5OS
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-WLB60587 MF-438

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".